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Previews
SC likely serves several functions beyond providingThis Little pIgR Went
covalent and noncovalent interactions with polymericto the Mucosa antibody ligands (Phalipon and Corthe´sy, 2003). It has
long been proposed that SC protects IgA from proteo-
lytic degradation in the relatively inhospitable environ-
ment of the mucosa. Emerging evidence also suggestsIn this issue, Hamburger et al. (2004) report the struc-
that free SC may also act directly to prevent pneumo-ture of the terminal domain of the polymeric immuno-
coccal infections independently of antibody-mediatedglobulin receptor (pIgR), which mediates the “suicide”
mechanisms, by blocking adherence, or may even betranscytosis of multimeric immunoglobulins (IgA,
coopted by some invading bacteria to infect epithelialIgM). This assists in reconciling decades of biochemis-
cells by accessing the transcytotic machinery.try, revealing a long-puzzling interaction.
While the pIgR ectodomain was almost immediately
recognized as consisting of a tandem repeat of fiveTwo of the five human antibody isotypes (IgA, IgD, IgE,
Ig V-like domains, it remained for the crystallographicIgG, and IgM) can multimerize, through intermolecular
analysis of the N-terminal, Ig binding domain, D1, (Ham-disulfide bonds, forming dimers to tetramers (IgA) or
burger et al., 2004) to reveal the unique aspects of thispentamers and hexamers (IgM). The cystine linkages
example of the superfamily—having to overcome, in theare either directly between short C-terminal extensions
process, an infrequent, but not unprecedented, type ofof the heavy chains (“tailpieces”) or to a small accessory
twinning associated with special cases of monoclinicmolecule, “joining” or J chain (Johansen et al., 2001).
space groups. In particular, the pIgR D1 CDRs displayThe importance of the multimeric immunoglobulins, par-
highly noncanonical conformations: a turn of helix inticularly IgA, is that they are the preponderate antibodies
CDR1, a very short, tightly-turning CDR2 and a distinct,found in the mucosa: the linings of the eye and the
tilted CDR3 conformation. These features not only havegenital, respiratory, and gastrointestinal tracts. Since
implications for the nature of the Ig binding site but alsothese surfaces represent the predominant routes of en-
limit possible intermolecular associations. As would betry for a variety of pathogens, components of humoral
expected, residues identified through years of previousimmunity that function here have long been appreciated
peptide binding and directed mutagenesis studies asas the “first line of defense” of the immune system.
affecting affinity are exposed as exerting these effectsIndeed, the amount of IgA secreted into the intestinal
both directly, by providing ligand contacts, and indi-lumen alone exceeds the total amount of IgG produced
rectly, by affecting local conformation. However, identi-in the body on a daily basis.
fying which is which is only now possible in light of theWhile the mucosal epithelium serves as an imperme-
three-dimensional structure. These studies also extend,able barrier, walling these compartments off from the
and beautifully complement, previous results from this
rest of the organism, it also functions to segregate im-
group detailing how antibodies (IgG, in this case) are
mune effector cells from invading organisms in the lu-
imported across the epithelium by the FcRn (Raghavan
men. To straddle this barrier, the immune system utilizes and Bjorkman, 1996) and by structural analyses of part
specialized cellular structures (M cells, Peyer’s patches) of one pIgR ligand, Fc (Herr et al., 2003).
and active transport pathways (transcytosis). To export The complementary surface plasmon resonance bind-
multimeric antibodies secreted by plasma cells (end- ing experiments performed by Hamburger and cowork-
stage differentiated B cells, comprising part of the ers (2004) show consistently, but most definitively, that
lymphoid tissue associated with mucosal epithelium), a pIgR has significant affinity only for multimeric antibody
receptor specific for multimeric antibodies, the poly- species that include J chain and that neither inclusion
meric immunoglobulin receptor (pIgR), is expressed on of tailpieces alone, nor the glycosylation state of the
epithelial cells, initially targeted to basolateral surfaces pIgR D1, affect binding. The parsimonious, though by
(Mostov, 1994). Here, pIgR noncovalently interacts with no means conclusive, explanation to account for the
ligand and is endocytosed. During or after transcytosis data is that J chain forms part of the footprint of pIgR.
to the apical surface of the cell, disulfide-exchange oc- The structure of J chain (which has no recognizable
curs between pIgR and IgA, covalently coupling the sequence similarity to any protein of known structure)
complex, and the pIgR extracellular moiety is hydrolyti- and its role in polymeric immunoglobulin assembly and
cally cleaved, releasing the complex into the extracellu- pIgR binding, are now the leading mysteries of this story.
lar space—hence the characterization of the transport Given the range of interactions observed in previously
as “suicidal”. The solubilized extracellular fragment of studied Ig/receptor complexes, and the complexity of
the pIgR is termed secretory component (SC); the com- dimeric IgA (two IgAs with tailpieces plus J chain), the
plex is termed secretory IgA (sIgA). Transcytosis of pIgR topological possibilities for the complete sIgA complex
also occurs constitutively, resulting in the secretion of are myriad. It has been argued, on the basis of the Fc/
free SC. Targeting is mediated by separable sequence FcRI complex structure (Herr et al., 2003), that the
elements located in the pIgR cytoplasmic domain; pIgR footprints of FcRI and pIgR on dimeric IgA likely over-
has long served as a model system for studying directed lap, but the detailed interactions are very likely dissimi-
transcytosis in polarized cells (Mostov and Cardone, lar, paralleling the distinct structures of pIgR and FcRI.
The extant binding data seem to preclude an IgE/1995).
Structure
1920
Figure 1. Interaction Surface Maps of Fc
and pIgR D1
Molecular surface representations of Fc
(Herr et al., 2003) and pIgR D1 (Hamburger
et al., 2004) domains are shown, colored by
chain (yellow or orange) for Fc and by atom
type (carbon, gray; oxygen, red; nitrogen,
blue) for pIgR. Ordered carbohydrates in the
Fc structure are shown as spheres, also col-
ored by atom type. Putative interaction sur-
faces are indicated: residues 402–410 (blue),
residues 430–443 (dark blue), and cysteine
311 (red) on the IgA Fc and the pIgR CDRs
(shades of green). The oblique view of the
Fc is necessitated by the somewhat buried
location of cysteine 311. What is not shown
are the IgA Fabs, tailpieces, J chain or the
whole other IgA molecule in the dimer, or the
remaining four Ig domains of SC. The figure
was prepared with PyMOL (DeLano, W.L. The
PyMOL Molecular Graphics System [2002];
http://www.pymol.org).
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